Delenex Therapeutics' Series A - III Round

Delenex Therapeutics raised a round of funding on November 07, 2013.

Delenex is a biopharmaceutical company focused on the development of locally or topically applied antibody therapeutics. Thereby Delenex aims at extending the benefits of proven antibody therapeutics …

Articles about Delenex Therapeutics' Series A - III Round: